Fuzhou Suoluomen Brother Network Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Fuzhou Suoluomen Brother Network Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include MAYAMANG. The owner is based in Fuzhou,Fujian,.
3216,Rm 1,Fl 28,Zhidi Square,
No. 89 Wusi Rd,Wenquan Str.,Gulou Dist,
Fuzhou,Fujian, 350000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Fuzhou Suoluomen Brother Network Technology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Fuzhou Suoluomen Brother Network Technology Co., Ltd. have?
Fuzhou Suoluomen Brother Network Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Fuzhou Suoluomen Brother Network Technology Co., Ltd. file in?
Fuzhou Suoluomen Brother Network Technology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus). Class 25 covers clothing, footwear, headgear.
What are Fuzhou Suoluomen Brother Network Technology Co., Ltd.'s most well-known trademarks?
Fuzhou Suoluomen Brother Network Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MAYAMANG. These are among 1 currently registered trademark in the portfolio.
What is Fuzhou Suoluomen Brother Network Technology Co., Ltd.'s trademark registration success rate?
Fuzhou Suoluomen Brother Network Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.